Munich, December 21, 2020: inCare, the digital oncology therapeutics company, announced that it has released its new ONCO CARE Platform.

inCare is offering digital oncology therapeutics solutions to address improvement in cancer care for patients and health care providers.

The newly released digital oncology platform ONCO CARE can be used as an adjunct or as part of chemotherapies for marketed products or products in development by optimizing and personalizing patient cancer care and health outcomes in combination with direct and earlier patient engagement.

ONCO CARE can contribute to increased patient compliance to pharmacological interventions, realtime data/feedback and patient-reported data and outcomes (PRO), Accelerated drug development by better and faster data assessment and improvement in clinical and health economics outcomes.

It is intended supporting the transformation of oncology care by extending digital health beyond monitoring and offering deeper insights about patient health patterns, data and medication treatment effectiveness and side effects, leading to more informed healthcare decisions and better outcomes for everyone involved.

About InCare

inCare is combining mobile applications, wearable and artificial intelligence technologies in a digital oncology medicine and therapy platform for everyone involved.

We are transforming cancer care by extending digital health and digital therapeutics beyond monitoring and offering deeper insights about patient health patterns, medication treatment effectiveness and side effects, leading to more informed healthcare decisions and better outcomes for everyone involved.

Media Contact: pr@incare.app

No Comment

Comments are closed.